BioNexus Gene Lab Corp. Earnings Per Share (Diluted)
BioNexus Gene Lab Corp. (BGLC) reported Earnings Per Share (Diluted) of -$0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- BioNexus Gene Lab Corp. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.12.
- BioNexus Gene Lab Corp. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.23.
- BioNexus Gene Lab Corp. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.40.
- BioNexus Gene Lab Corp. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.34, a 403.54% decline year-over-year.
- BioNexus Gene Lab Corp. earnings per share, diluted for fiscal 2024 was -$0.09.
- BioNexus Gene Lab Corp. earnings per share, diluted for fiscal 2023 was -$0.17.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.12 10-Q · filed 2026-08-14 | -$0.34 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$0.23 10-Q · filed 2026-05-15 | ||||
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-14 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.08 10-Q · filed 2025-11-14 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-14 | |
| 2025-06-30 | -$0.34 10-Q · filed 2026-08-14 | -$0.69 10-Q · filed 2026-08-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-08-14 | |
| 2025-03-31 | -$0.35 10-Q · filed 2026-05-15 | -$0.04 10-Q · filed 2025-05-15 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2024-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-04-14 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-04-14 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-04-14 | -$0.09 10-K · filed 2025-04-15 | |
| 2024-09-30 | -$0.75 10-Q · filed 2025-11-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.70 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $0.11 10-Q · filed 2025-08-18 | $0.05 10-Q · filed 2025-08-18 | |||
| 2024-03-31 | -$0.01 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | -$0.17 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |